Details

Autor(en) / Beteiligte

• Isaeva, Olga V.
• Kyuregyan, Karen K.
• Karlsen, Anastasia A.
• Kuzmin, Oleg V.
• Potemkin, Ilya A.
• Kichatova, Vera S.
• Asadi Mobarkhan, Fedor A.
• Mullin, Eugeniy V.
• Kozhanova, Tatyana V.
• Manuylov, Victor A.
• Pochtovyy, Andrey A.
• Gushchin, Vladimir A.
• Saryglar, Anna A.
• Ilchenko, Lyudmila Yu
• Mikhailov, Mikhail I.

Titel

Silent HDV epidemics culminates in high levels of liver cirrhosis in endemic region despite 20 years of HBV vaccination

Ist Teil von

• Journal of viral hepatitis, 2023-03, Vol.30 (3), p.182-194

Ort / Verlag

England

Erscheinungsjahr

2023

Link zum Volltext

Quelle

Wiley Online Library Journals Frontfile Complete

Beschreibungen/Notizen

• The hepatitis delta virus (HDV) is believed to be a vanishing infection in countries with successful hepatitis B virus (HBV) vaccination programs. We assessed the current status of HDV infection in Tuva, a region of the Russia that has been highly endemic for HBV. The proportion of HDV‐infected patients among HBsAg‐positive patients in the regional registry in 2020 was 32.7% (786/2401). An analysis of the medical records of 514 HDV patients demonstrated that 37.5% (193/514) had liver cirrhosis at the first doctor's visit, and 7.4% of patients lived in families where another family member had HDV. All HDV patients were infected with genotype HDV‐1, 94.5% had HBV genotype D, and 5.5% had genotype A. A serosurvey conducted among 1170 healthy volunteers showed that the average detection rate of HBsAg with anti‐HDV was 1.0% (95% CI: 0.57–1.81%). No anti‐HDV positive samples were detected in participants aged under 30 years. The HBsAg/anti‐HDV positivity rate peaked at 7.4% in patients aged 50–59 years, which was significantly higher than in a similar age cohort surveyed in 2008 (1.6%, p < .0001). A Bayesian analysis showed that HDV circulation in Tuva resulted from two waves of introduction, the first in the 1810s (95% HPD: 1741–1834) from Central Asia, and the second in the 1960s (95% HPD: 1953–1979) from Russia. HBV has a much longer history of circulation in Tuva with the MRCA for the predominant genotype HBV‐D dated to 972 (95% HPD: 535–1253) for subtype D1, 1274 (95% HPD: 936–1384) for D2, and 1173 (95% HPD: 1005–1618) for D3. A SkyGrid reconstruction of population dynamics showed an increase in the intensity of HDV spread in recent decades. This situation shows the need for HDV screening and prevention measures among people living with HBV.